Physician profile
Ryan Conley
NPI 1417016312
$2,255.72
in general payments reported to CMS, 2019-2025
11 companies · $906 in 2025
The $906 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $115 · 2021: $32.71 · 2022: $35.77 · 2023: $252 · 2024: $483 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.13 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $978.18 | 2019-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Glaukos Corporation | $781.29 | 2019-2025 | Photrexa Viscous and Photrexa |
| Abbvie INC. | $216.84 | 2023-2024 | Vuity, Durysta, Lumigan |
| Sun Pharmaceutical Industries INC. | $71.66 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $64.66 | 2019-2020 | |
| Allergan, INC. | $42.56 | 2019 | |
| Rxsight INC | $27.78 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.53 | 2020 | |
| Astellas Pharma US INC | $19.96 | 2025 | Izervay |
| Kala Pharmaceuticals, INC. | $17.61 | 2019 | |
| Sight Sciences, INC. | $14.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.